CMP as on 04-Jul-22 15:47₹ 130.25
Turnover (lac)₹ 17
Prev. Close₹ 128.25
Day's Vol (shares)₹ 13,213
Day's Range (₹)
CMP as on04-Jul-22 15:28₹ 130.90
Turnover (lac)₹ 3
Prev. Close₹ 128.35
Day's Vol (shares)₹ 2,483
On completion of the inspection, PBPL was issued an FDA Form 483 with eight (8) observations that are related to improvements in existi
As part of this arrangement, the pharma giant, Mankind Pharma, will be retaining the companys well-trained sales and marketing team alr
Under the terms of the funding agreement, THST1 and Panacea Biotec have committed to achieving equitable access to the outputs of this
Consolidated EBITDA for the quarter ended December 2021 declined 20.66% yoy at Rs13.52 crore.
The Transaction is expected to be completed in the current financial year.
The Board would also consider convening Extra-ordinary General Meeting of its shareholders for seeking their approval.
The first batch will be distributed in India through a partner of RDIF and Panacea Biotec Dr Reddys Laboratories.
Sputnik V has been registered in 67 countries globally with a total population of over 3.5 billion people.
However, its net sales rose 14.8% yoy to Rs624.81cr in FY21 over FY20.
The first batch produced at Panacea Biotecs facilities at Baddi will be shipped to the Gamaleya Center for quality control.
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity